aids2031 is a international consortium of partners examining the future of the HIV/AIDS epidemic. The Costs and Financing Working Group is focused on modeling and analyzing the long-term costs and financing of the epidemic, and examining scenarios in which major policy shifts now can improve the future expenditure and financing situation.
R4D is identifying innovative approaches to financing global health R&D that reduce barriers and risk in the development of new health technologies. New and improved products are needed to reduce the burden of disease, but creating these products requires difficult long-term scientific efforts, with uncertain return on investment.
The Transparency and Accountability Program (TAP) strengthens the capacity of independent monitoring organizations (IMOs) in developing countries to promote improvements in social sector public spending and better hold their governments accountable for expenditure decisions and actions.
The Ministerial Leadership Initiative for Global Health (MLI) brings together expertise in leadership development and specialized technical areas needed to design and successfully make and implement health sector policy. As a technical partner in MLI, R4D is providing technical assistance focused on improvements in equitable financing and donor harmonization in Ethiopia, Mali, Nepal, Senegal, and Sierra Leone.
Transforming Health Systems is an initiative of the Rockefeller Foundation that seeks to strengthen health systems by supporting global level analysis of policies that drive a global health systems agenda and country level work to implement catalytic demonstrations of health systems transformation.
